Kui Wang

Director of mRNA Sciences & Editing Technology Development Verve Therapeutics

Seminars

Tuesday 22nd July 2025
Scaling mRNA Cancer Vaccine Production & Processes With Automation Towards Better Efficiency & Speed – Chair
Tuesday 22nd July 2025
Optimizing mRNA Analytics & Process Strategies to Better Characterize mRNA Drug Substance & Products – Chair
Tuesday 22nd July 2025
Developing a Robust & Scalable CMC Platform to Ensure Quality Manufacturing mRNA-Based Therapeutics & Vaccines Globally – Chair
Kui Wang 5th mRNA-Based Therapeutics Summit